Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10 | 11 | 13 | 12 | 9 |
| Accounts receivable | 118 | -112 | 135 | -158 | 17 |
| Accounts payable and accrued liabilities | -48 | 233 | -16 | -200 | 147 |
| Other Working Capital | 491 | -1,387 | -317 | -346 | -218 |
| Other Operating Activity | -5,059 | -1,243 | -1,335 | -86 | -814 |
| Operating Cash Flow | $-4,488 | $-2,497 | $-1,521 | $-778 | $-860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 93 | N/A | N/A | N/A | -8 |
| Other Investing Activity | 2 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $96 | $N/A | $N/A | $N/A | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -22 | -197 | 125 | 6,922 | N/A |
| Common Stock Issued | 2,095 | N/A | N/A | N/A | 0 |
| Other Financing Activity | -1,644 | 17,923 | 0 | 0 | 1,365 |
| Financing Cash Flow | $429 | $17,726 | $125 | $6,922 | $1,365 |
| Beginning Cash Position | 20,782 | 5,577 | 6,959 | 815 | 248 |
| End Cash Position | 16,819 | 20,782 | 5,577 | 6,959 | 807 |
| Net Cash Flow | $-3,963 | $15,227 | $-1,397 | $6,144 | $497 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,488 | -2,497 | -1,521 | -778 | -860 |
| Capital Expenditure | -5 | N/A | N/A | N/A | -8 |
| Free Cash Flow | -4,493 | -2,497 | -1,521 | -778 | -868 |